Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs
Sandra M Axiak1, Kim A Selting1, Charles J Decedue2, Carolyn J Henry1,3, Deborah Tate1, Jahna Howell2, K James Bilof1, Dae Y Kim4 1Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, MO, USA; 2CritiTech Inc, Lawrence, KS, USA; 3Department of Internal Medicine, Division o...
Enregistré dans:
Auteurs principaux: | Axiak SM, Selting KA, Decedue CJ, Henry CJ, Tate D, Howell J, Bilof KJ, Kim DY |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8fc2a7a437dd455b942a4a9d01986cb2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancer
par: Axiak-Bechtel SM, et autres
Publié: (2014) -
A dose-escalating toxicology study of the candidate biologic ELP-VEGF
par: Jamarius P. Waller, et autres
Publié: (2021) -
Compact Thermal Imager (CTI) for Atmospheric Remote Sensing
par: Dong L. Wu, et autres
Publié: (2021) -
Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors
par: Hui-Jen Tsai, et autres
Publié: (2021) -
Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors
par: Marcel A. Schneider, et autres
Publié: (2021)